Search - tctmd.com

Displaying 861 - 880 of 1039

Sort: Relevancy | Date

News Conference News TCT 2012

ADAPT-DES: Poor Clopidogrel Response Not Predictive of 1-Year Mortality

October 25, 2012

Presentation TCT 2012

ADAPT-DES One Year: A Large-Scale, Multicenter, Prospective, Observational Study of the Impact of Clopidogrel and Aspirin Hyporesponsiveness on Patient Outcomes

Presenter: Gregg Stone

October 25, 2012

News Industry News

8500+ Patient Trial Validates Association between High Platelet Reactivity and 1-Year Cardiovascular Outcomes at TCT 2012

October 25, 2012

Presentation TCT 2012

MitraClip for Functional MR: COAPT: Update and Expectations

Presenter: Gregg Stone

October 24, 2012

News Industry News

Reported at TCT 2012: InspireMD MGuard Stent Meets Primary Endpoint of MASTER Trial, Significantly Improving Prospects of Heart Attack Survival

October 24, 2012

News Conference News TCT 2012

Paradigm Shift from Ischemia to Vulnerable Plaque Needed to Prevent Sudden Coronary Death

October 24, 2012

News Conference News TCT 2012

Mesh-Covered Stent Shines in MASTER Trial

October 24, 2012

News Industry News

Mesh-Covered Stent Improves Restoration of Blood Flow in Heart Attack Patients Undergoing Angioplasty

October 24, 2012

Presentation TCT 2012

MASTER: A Prospective, Randomized Trial of a PET Micronet Mesh-Covered Stent vs. Standard Stents in Patients with ST-Segment Elevation Myocardial Infarction

Presenter: Gregg Stone

October 24, 2012

Presentation TCT 2012

Introduction to an Extraordinary Life

Presenter: Gregg Stone

October 24, 2012

Presentation TCT 2012

Evolutionary Revascularization Strategies for Coronary Artery Disease: From Anatomy to Ischemia to Vulnerable Plaque

Presenter: Gregg Stone

October 24, 2012

Presentation TCT 2012

Bivalirudin: New Analyses, New Studies

Presenter: Gregg Stone

October 24, 2012

Presentation TCT 2012

What Will We Learn from the EXCEL Trial that We Do Not Already Know?

Presenter: Gregg Stone

October 23, 2012

Presentation TCT 2012

The New Anticoagulants: A Meaningful Step Forward?

Presenter: Gregg Stone

October 23, 2012

Presentation TCT 2012

TCT-52. Bivalirudin Reduces Cardiac Mortality in Patients with and Without Major Bleeding: The HORIZONS-AMI Trial

Presenter: Gregg Stone

October 23, 2012

Presentation TCT 2012

Introductory Lecture. A New Paradigm Revisited: From Ischemia to Vulnerable Plaque

Presenter: Gregg Stone

October 23, 2012

Presentation TCT 2012

COAPT

Presenter: Gregg Stone

October 23, 2012

News Conference News TCT 2012

VERDICT/F1RST Confirms Modest Correlation Between IVUS, MLA and FFR

October 23, 2012

Presentation TCT 2012

The Mitral VARC Initiative

Presenter: Gregg Stone

October 23, 2012

Presentation TCT 2012

ABSORB III and IV (Abbott Vascular) Pivotal Clinical Trial Program

Presenter: Gregg Stone

October 23, 2012

Advertisement

ADAPT-DES: Poor Clopidogrel Response Not Predictive of 1-Year Mortality

ADAPT-DES One Year: A Large-Scale, Multicenter, Prospective, Observational Study of the Impact of Clopidogrel and Aspirin Hyporesponsiveness on Patient Outcomes

8500+ Patient Trial Validates Association between High Platelet Reactivity and 1-Year Cardiovascular Outcomes at TCT 2012

MitraClip for Functional MR: COAPT: Update and Expectations

Reported at TCT 2012: InspireMD MGuard Stent Meets Primary Endpoint of MASTER Trial, Significantly Improving Prospects of Heart Attack Survival

Paradigm Shift from Ischemia to Vulnerable Plaque Needed to Prevent Sudden Coronary Death

Mesh-Covered Stent Shines in MASTER Trial

Mesh-Covered Stent Improves Restoration of Blood Flow in Heart Attack Patients Undergoing Angioplasty

MASTER: A Prospective, Randomized Trial of a PET Micronet Mesh-Covered Stent vs. Standard Stents in Patients with ST-Segment Elevation Myocardial Infarction

Introduction to an Extraordinary Life

Evolutionary Revascularization Strategies for Coronary Artery Disease: From Anatomy to Ischemia to Vulnerable Plaque

Bivalirudin: New Analyses, New Studies

What Will We Learn from the EXCEL Trial that We Do Not Already Know?

The New Anticoagulants: A Meaningful Step Forward?

TCT-52. Bivalirudin Reduces Cardiac Mortality in Patients with and Without Major Bleeding: The HORIZONS-AMI Trial

Introductory Lecture. A New Paradigm Revisited: From Ischemia to Vulnerable Plaque

COAPT

VERDICT/F1RST Confirms Modest Correlation Between IVUS, MLA and FFR

The Mitral VARC Initiative

ABSORB III and IV (Abbott Vascular) Pivotal Clinical Trial Program

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content